Current Report Filing (8-k)

0001598308 false 0001598308 2021-11-08 2021-11-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

 

Date of Report (Date of earliest event reported): November 8, 2021

 

GLOBAL WHOLEHEALTH PARTNERS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Nevada	000-56035	46-2316220
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

1130 Calle Cordillera San Clemente, CA	92673
(Address of Principal Executive Offices)	(Zip Code)

 

Registrant's telephone number, including area code [phone]

N/A
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

1

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Section 8 - Other Events 

Item 8.01 Other Events.

 

Global Wholehealth Partners Corporation (the “Company”) has established a purchasing relationship with Kisso, LLC (“Kisso”), a supplier of Emergency Use Authorization (EUA) antigen tests for COVID-19. On November 8, 2021, the Company purchased 10,000 boxes of EUA Approved COVID-19 Home Test Kits from Kisso for distribution. Sales from this purchase are expected to generate revenue for the Company. 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

	GLOBAL WHOLEHEALTH PARTNERS CORPORATION (Registrant)
Date: November 12, 2021	By: /s/ Charles Strongo Charles Strongo Chief Executive Officer

  

 

2